课题基金 / 基金详情

Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Vortioxetine for Cognitive Deficits in Persons with Post-COVID-19 Condition

评估沃替西汀对 COVID-19 后患者认知缺陷的随机、双盲、安慰剂对照研究

批准号：

467059

负责人：

Lui Leanna

金额：

$1.27万

依托单位：

University of Toronto

依托单位国家：

加拿大

项目类别：

Studentship Programs

财政年份：

2021

资助国家：

加拿大

项目状态：

已结题

起止时间：

2021-12-01 至 2022-12-01

来源：

https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=467059&lang=en

关键词：

Anhedonia Antidepressant Cognition Covid-19 Function Post Covid-19 Condition Quality Of Life Reward Wellbeing

项目摘要

项目成果

相似基金

相关文献

中文摘要

翻译

点击翻译按钮获取中文摘要

英文摘要

Since the declaration of the COVID-19 pandemic by the World Health Organization, over 259 million people have tested positive for COVID-19. A notable percentage of individuals who were previously infected with COVID-19 continue to experience persisting an

期刊论文(0)

专著(0)

科研奖励(0)

会议论文